February 26th 2025, 4:24pm
An expert explained a potential side effect associated with treatment consisting of Itovebi for breast cancer.
February 26th 2025, 4:12pm
Dr. Yuan Yuan breaks down studies for patients with breast cancer, such as the phase 3 CompassHER2 RD Trial.
February 26th 2025, 4:03pm
An expert shares information on a pair of noteworthy active trials in breast cancer that patients should be aware of.
February 25th 2025, 5:00pm
An expert explains what biliary tract cancers are and the current landscape of treatment as well as future advancements.
February 24th 2025, 10:00pm
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it.
February 24th 2025, 5:00pm
An expert explains that the GAP regimen did not improve overall survival in advanced biliary tract cancer versus the doublet and increased severe side effects.
February 23rd 2025, 3:00pm
Dr. Laurence Albiges discusses triplet therapies, highlighting which patients with RCC may garner the most benefit with this treatment intensification.
February 22nd 2025, 3:00pm
Dr. Chandler Park discusses the importance of genetic testing and personalized care in patients with genitourinary cancers.
February 21st 2025, 10:00pm
An expert explains the importance of genetic testing in metastatic colorectal cancer, as recent FDA approval highlights its role in guiding targeted treatments.
February 20th 2025, 5:00pm
Dr. Catherine Wu discussed the unique aspects of clear cell renal cell carcinoma and the challenges of targeting it with a vaccine.
A Cancer Survivor Rethinks Cancer Ghosting
A Story of Staying Active After a Lung Cancer Diagnosis
Experts Discuss New Advances in Bladder Cancer Following ESMO 2025
What I Learned About Previvorship and Representation in Social Media